Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity.
|
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
Cm92Sf5TDhc8pLtb